Partnervest Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Partnervest Advisory Services’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,524	Closed	-$223K	–	186
2015 Q3	$223K	Sell	4,524 -6,192	-58%	-$355K	0.13%	143
2015 Q2	$624K	Sell	10,716 -342	-3%	-$20K	0.31%	53
2015 Q1	$636K	Sell	11,058 -156	-1%	-$8.53K	0.33%	52
2014 Q4	$566K	Buy	11,214 +420	+4%	+$20.5K	0.27%	67
2014 Q3	$505K	Sell	10,794 -150	-1%	-$6.77K	0.26%	68
2014 Q2	$493K	Buy	10,944 +4,629	+73%	+$199K	0.22%	67
2014 Q1	$267K	Buy	6,315 +1,860	+42%	+$78K	0.12%	120
2013 Q4	$175K	Sell	4,455 -75	-2%	-$2.81K	0.08%	158
2013 Q3	$161K	Buy	4,530 +1,710	+61%	+$60.2K	0.08%	142
2013 Q2	$94K	Buy	+2,820	New	+$93.7K	0.04%	164

Other funds holding IHE

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Partnervest Advisory Services's IHE Position: Q4 2015 in Review

Partnervest Advisory Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 4,524 shares — an estimated $223K sold.

Partnervest Advisory Services first reported a position in IHE in Q2 2013 and held it in 10 quarters. The position peaked at $636K in Q1 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

Partnervest Advisory Services reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Partnervest Advisory Services sold 4,524 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $223K.
Partnervest Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
Partnervest Advisory Services's iShares US Pharmaceuticals ETF position peaked at $636K in Q1 2015.
103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Partnervest Advisory Services's 13F filing for Q4 2015, filed 12 Feb 2016.